AZLIN Drug Patent Profile
When do Azlin patents expire, and what generic alternatives are available?
Azlin is a drug marketed by Bayer Pharms and is included in three NDAs.
The generic ingredient in AZLIN is azlocillin sodium. There is one drug master file entry for this compound. Additional details are available on the azlocillin sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AZLIN?
- What are the global sales for AZLIN?
- What is Average Wholesale Price for AZLIN?
Summary for AZLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 7,181 |
| DailyMed Link: | AZLIN at DailyMed |
US Patents and Regulatory Information for AZLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-001 | Sep 8, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-003 | Sep 8, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-002 | Sep 8, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062417-003 | Oct 12, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062417-001 | Oct 12, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 050562-001 | Sep 3, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 050562-002 | Sep 3, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
